Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now

"The greatest wealth is health."         - Virgil


      Advertisement

PANCREATIC CARCINOMA METASTATIC side effect

What is PANCREATIC CARCINOMA METASTATIC ?
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with PANCREATIC CARCINOMA METASTATIC

BEVACIZUMAB  BYETTA  CALCIUM  ENBREL  INFLIXIMAB  NATALIZUMAB  PANCREASE  PROGRAF  REMICADE  REVATIO  SIROLIMUS  TYSABRI  XELODA  ZOCOR  


PANCREATIC CARCINOMA METASTATIC : Byetta Side Effects Report #5655481-2
Consumer or non-health professional from UNITED STATES reported BYETTA problem on Feb 28, 2008. Male patient, weighting 172.0 lb, was diagnosed with diabetes mellitus, hypertension, hyperlipidaemia and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma metastatic, pancreatitis acute, weight decreased, . BYETTA dosage: unknown. During the same period patient was treated with METFORMIN, AVANDIA, ASPIRIN, ALTACE, LIPITOR, TRICOR, ZETIA. Patient was hospitalized. Patient recovered.

PANCREATIC CARCINOMA METASTATIC : Remicade Side Effects Report #5659563-0
REMICADE problem was reported by a Health Professional from UNITED STATES on Feb 29, 2008. Male patient, weighting 200.0 lb, was diagnosed with rheumatoid arthritis, hypertension, lipids abnormal and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma metastatic, . REMICADE dosage: unknown. During the same period patient was treated with METHOTREXATE, ATENOLOL, CLONIDINE, DIAVAN, MAXZIDE, NIACIN. Patient recovered.

PANCREATIC CARCINOMA METASTATIC : Remicade Side Effects Report #5661526-6
Physician from SPAIN reported REMICADE problem on Mar 03, 2008. Female patient, 50 years of age, was diagnosed with crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma metastatic, . REMICADE dosage: unknown. During the same period patient was treated with IMUREL. Patient recovered.

PANCREATIC CARCINOMA METASTATIC : Enbrel Side Effects Report #5661649-1
ENBREL problem was reported by a Consumer or non-health professional from SPAIN on Feb 28, 2008. Male patient, 53 years of age, was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma metastatic, . ENBREL dosage: unknown. Patient died.

PANCREATIC CARCINOMA METASTATIC : Enbrel Side Effects Report #5640623-5
Health Professional from UNITED KINGDOM reported ENBREL problem on Feb 14, 2008. Male patient, 61 years of age, was diagnosed with psoriasis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma metastatic, skin nodule, . ENBREL dosage: unknown. Patient died on 02/14/2008.

PANCREATIC CARCINOMA METASTATIC : Remicade Side Effects Report #5600904-8
REMICADE problem was reported by a Physician from JAPAN on Jan 17, 2008. Female patient, weighting 114.6 lb, was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma metastatic, . REMICADE dosage: unknown. Patient was hospitalized. Patient died on 04/16/2007.

PANCREATIC CARCINOMA METASTATIC : Infliximab Side Effects Report #5524790-X
Physician from UNITED KINGDOM reported INFLIXIMAB problem on Nov 12, 2007. Female patient was treated with INFLIXIMAB. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma metastatic, . INFLIXIMAB dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient died.

PANCREATIC CARCINOMA METASTATIC : Sirolimus Side Effects Report #5400123-4
SIROLIMUS problem was reported by a Physician from UNITED STATES on July 19, 2007. Male patient, weighting 191.2 lb, was diagnosed with prophylaxis against transplant rejection, hyperlipidaemia, hypertension and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma metastatic, . SIROLIMUS dosage: unknown. During the same period patient was treated with ZOCOR, LANTUS, COZAAR, SEPTRA, NOVOLOG. Patient was hospitalized. Patient died on 07/16/2007.

PANCREATIC CARCINOMA METASTATIC : Sirolimus Side Effects Report #5400123-4
Physician from UNITED STATES reported SIROLIMUS problem on July 19, 2007. Male patient, weighting 191.2 lb, was diagnosed with prophylaxis against transplant rejection, hyperlipidaemia, hypertension and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma metastatic, . SIROLIMUS dosage: unknown. During the same period patient was treated with ZOCOR, LANTUS, COZAAR, SEPTRA, NOVOLOG. Patient was hospitalized. Patient died on 07/16/2007.

PANCREATIC CARCINOMA METASTATIC : Zocor Side Effects Report #5605765-9
ZOCOR problem was reported by a Consumer or non-health professional from CANADA on Jan 16, 2008. Male patient, 60 years of age, was diagnosed with acute coronary syndrome and was treated with ZOCOR. After drug was administered, patient experienced the following problems/side effects: metastases to liver, pancreatic carcinoma metastatic, . ZOCOR dosage: 40 MG/DAILY PO. During the same period patient was treated with COVERSYL, ELAVIL, MONOCOR, NITRO, PLAVIX, PREVACID. Patient was hospitalized. Patient died.

PANCREATIC CARCINOMA METASTATIC : Infliximab Side Effects Report #5520326-8
Physician from UNITED STATES reported INFLIXIMAB problem on Nov 16, 2007. Female patient, weighting 117.0 lb, was diagnosed with crohn's disease and was treated with INFLIXIMAB. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, pancreatic carcinoma metastatic, . INFLIXIMAB dosage: unknown. During the same period patient was treated with MESALAMINE, QUESTRAN. Patient died on 11/04/2007.

PANCREATIC CARCINOMA METASTATIC : Calcium Side Effects Report #5469860-X
CALCIUM WITH VITAMIN D problem was reported by a Physician from UNITED STATES on Sept 12, 2007. Female patient, 68 years of age, weighting 159.0 lb, was diagnosed with hypersensitivity, osteoporosis and was treated with CALCIUM WITH VITAMIN D. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, pancreatic carcinoma metastatic, pulmonary embolism, . CALCIUM WITH VITAMIN D dosage: unknown. During the same period patient was treated with CALCIUM WITH VITAMIN D, ZYRTEC, ASPIRIN, SYNTHROID, EVISTA. Patient recovered.

PANCREATIC CARCINOMA METASTATIC : Xeloda Side Effects Report #5416798-X
Health Professional from UNITED STATES reported XELODA problem on Aug 08, 2007. Male patient, 64 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: fluid retention, pancreatic carcinoma metastatic, . XELODA dosage: unknown. Patient was hospitalized. Patient died on 07/11/2007.

PANCREATIC CARCINOMA METASTATIC : Natalizumab Side Effects Report #5424465-1
NATALIZUMAB problem was reported by a Physician from GERMANY on Aug 10, 2007. Male patient, 55 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: metastases to liver, pancreatic carcinoma metastatic, . NATALIZUMAB dosage: 300 MG; QM; IV. During the same period patient was treated with CIPRALEX, MIRTAZAPINE. Patient recovered.

PANCREATIC CARCINOMA METASTATIC : Revatio Side Effects Report #5388576-1
Physician from GERMANY reported REVATIO problem on July 05, 2007. Female patient was diagnosed with pulmonary hypertension and was treated with REVATIO. After drug was administered, patient experienced the following problems/side effects: diarrhoea, pancreatic carcinoma metastatic, . REVATIO dosage: unknown. During the same period patient was treated with BOSENTAN. Patient recovered.

PANCREATIC CARCINOMA METASTATIC : Revatio Side Effects Report #5388576-1
REVATIO problem was reported by a Physician from GERMANY on July 05, 2007. Female patient was diagnosed with pulmonary hypertension and was treated with REVATIO. After drug was administered, patient experienced the following problems/side effects: diarrhoea, pancreatic carcinoma metastatic, . REVATIO dosage: unknown. During the same period patient was treated with BOSENTAN. Patient recovered.

PANCREATIC CARCINOMA METASTATIC : Tysabri Side Effects Report #5682167-0
Consumer or non-health professional from GERMANY reported TYSABRI problem on Mar 13, 2008. Male patient, 55 years of age, weighting 152.1 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: helicobacter gastritis, metastases to liver, pancreatic carcinoma metastatic, weight decreased, . TYSABRI dosage: 300 MG; QM; IV. During the same period patient was treated with CIPRALEX, MIRTAZAPINE. Patient died on 01/22/2008.

PANCREATIC CARCINOMA METASTATIC : Xeloda Side Effects Report #5476845-6
XELODA problem was reported by a Health Professional from UNITED STATES on Sept 24, 2007. Male patient, 42 years of age, weighting 257.1 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: oral mucosal blistering, palmar-plantar erythrodysaesthesia syndrome, pancreatic carcinoma metastatic, . XELODA dosage: unknown. Patient died on 07/27/2007.

PANCREATIC CARCINOMA METASTATIC : Pancrease Side Effects Report #5502212-2
Consumer or non-health professional from CANADA reported PANCREASE problem on Sept 24, 2007. Male patient was treated with PANCREASE. After drug was administered, patient experienced the following problems/side effects: faecal volume increased, faeces discoloured, pancreatic carcinoma metastatic, weight decreased, . PANCREASE dosage: unknown. During the same period patient was treated with VASOTEC, DOCUSATE, HYDROMORPH, CIMETIDINE, EFFEXOR, FLOMAX, MUTLIVITAMINS. Patient recovered.

PANCREATIC CARCINOMA METASTATIC : Prograf Side Effects Report #5448472-8
PROGRAF problem was reported by a Physician from UNITED STATES on Sept 07, 2007. Male patient, weighting 246.3 lb, was diagnosed with prophylaxis against transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: adenocarcinoma pancreas, hepatic neoplasm malignant, pancreatic carcinoma metastatic, . PROGRAF dosage: unknown. During the same period patient was treated with NORVASC, ACTIGALL, BACTRIM, METOPROLOL TARTRATE, ASPIRIN, DILAUDID. Patient died on 06/26/2006.

PANCREATIC CARCINOMA METASTATIC : Revatio Side Effects Report #5428043-X
Physician from GERMANY reported REVATIO problem on Aug 21, 2007. Female patient, weighting 77.16 lb, was diagnosed with pulmonary hypertension and was treated with REVATIO. After drug was administered, patient experienced the following problems/side effects: cardiac failure, diarrhoea, pancreatic carcinoma metastatic, . REVATIO dosage: DAILY DOSE:30MG. During the same period patient was treated with BOSENTAN. Patient was hospitalized. Patient recovered.

PANCREATIC CARCINOMA METASTATIC : Bevacizumab Side Effects Report #5440538-1
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Aug 27, 2007. Male patient, 52 years of age, weighting 169.8 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: disease progression, malignant neoplasm progression, pancreatic carcinoma metastatic, . BEVACIZUMAB dosage: 10 MG/M2, DAYS 1+15/28DC. During the same period patient was treated with ERLOTINIB, GEMCITABINE, ATIVAN, CELEXA, LIDOCAINE MAALOX, DIPHENHYDRAMINE, REGLAN, SENNA. Patient died on 08/06/2007.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about PANCREATIC CARCINOMA METASTATIC side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about PANCREATIC CARCINOMA METASTATIC